Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-104447
Filing Date
2021-08-12
Accepted
2021-08-12 21:01:30
Documents
1
Period of Report
2021-08-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2124724-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2124724-1_4seq1.xml 4 9585
  Complete submission text file 0001104659-21-104447.txt   11600
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40703 | Film No.: 211169408

Mailing Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40703 | Film No.: 211169407

Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Issuer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)